Overview
Much progress has been made in managing and treating atopic dermatitis (AD) within the past few years. This 3-day conference will focus exclusively on AD and the complex information that has accrued around proper diagnosis, treatment, and management. Since its founding in 2019, Revolutionizing Atopic Dermatitis has become a fixture in dermatology, providing the highest-quality evidence-based and cutting-edge education in AD.
RAD is where your goal to improve patients’ lives harmonizes with meaningful discussions and groundbreaking concepts in atopic dermatitis. At this dynamic gathering, evidence drives the conversation, and strategies to step up care are conceived, giving you an unparalleled platform to expand your skills. Plus, this year, we’re turning up the energy in Nashville. Get ready to experience Nashville’s vibrant culture and iconic music scene while you update your knowledge and network with experts, right here at RAD!
Learning Objectives
- EVALUATE the efficacy, safety, and mechanisms of action of available treatments for AD, including biologics, JAK inhibitors, and topical therapies, while discussing emerging options in the pipeline.
- APPLY patient-centric approaches to AD management, incorporating disease severity, comorbidities, and patient preferences to optimize outcomes.
- REVIEW and implement guideline-directed care for AD, focusing on age-specific recommendations and treatment algorithms.
- UTILIZE effective communication techniques to improve patient adherence, manage expectations, and address concerns related to treatment options.
Program Co-Chairs
Jonathan I. Silverberg, MD, PhD, MPH; Raj Chovatiya, MD, PhD, MSCI
To view full profile, click on the Program Chair tab above.